Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Opiant Pharmaceuticals, Inc.

TRADE

NASDAQ: OPNTHealthcare / Biotechnology / -
17.21+0.21+1.24%Vol 11 9411Y Perf -51.61%
Oct 19th, 2018 16:00
BID17.04 ASK17.21
Open16.95 Previous Close17.00
Pre-Market- After-Trading-
 - -%  - -%
Target Price
47.00 
Analyst Rating
Strong Buy 1.00
Potencial %
173.10 
Finscreener Ranking
★★★★★     63.00
Insiders Trans % 3/6/12M
-64/3/-18 
Value Ranking
★★+     49.47
Insiders Value % 3/6/12M
-95/-64/-94 
Growth Ranking
★★★+     54.89
Insiders Shares Cnt. % 3/6/12M
-94/-63/-93 
Income Ranking
 —    -
Market Cap (mil)51 
Earnings Rating
Price Range Ratio 52wk %
12.65 
Earnings Date

Today's Price Range

16.9117.43

 

52wk Range

12.7548.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-23.17%
3 Months
12.85%
6 Months
-13.26%
1 Year
-51.61%
3 Years
139.03%
5 Years
270.11%

Quotes

Name / TickerPriceChg.Chg.%
OPNT17.210.21001.24
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.30
Current Ratio 3.40
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -2 873.20
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin12.20
EBITDA Margin12.20
Pre-tax Profit Margin-
Profit Margin-55.10
ValuationValueIndustryS&P 500US Markets
PE Ratio 4.60
PB Ratio 7.55
PS Ratios 3.82
Price to Cash Flow 7.90
Price to Free Cash Flow -20.00
Cash Flow Per Share 2.17
Price to Tangible Book7.56
Book Value per Share2.27
Enterprise Value (in ths.)51 977
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)822.69
ROE last 12 Months -159.11
Return on Assets (5Y Avg) -28.20
ROA last 12 Months -81.56
Return on Capital (5Y Avg) -
ROC last 12 Months -434.35
Return on invested Capital Q -19.53
Return on invested Capital Y-7.86
Assets Turnover1.30
Receivables Turnover4.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)16 571
Revenue per Share 4.49
Revenue Growth 3 Years 99.59
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-1.26-0.5258.73
Q01 2018-1.19-2.77-132.77
Q04 2017-0.87-0.1780.46
Q03 2017-0.82-1.55-89.02
Q02 2017-0.854.91677.65
Q01 2017-1.14-0.3073.68
Q04 2016--0.52-
Q03 2016-0.15-
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.1190.09Positive
12/2018 QR-0.1090.00Positive
12/2018 FY-4.7019.80Positive
12/2019 FY3.93192.69Positive
Next Report Date9th Aug 2018
Estimated EPS Next Report-1.26
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume11 941
Shares Outstanding (in ths.)2 980
Trades Count40
Dollar Volume169 289
Avg. Volume41 830
Avg. Weekly Volume25 878
Avg. Monthly Volume69 634
Avg. Quarterly Volume61 774

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

42%58%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x